ATNX - Athenex Inc. (ATNX) CEO Johnson Lau on Q4 2021 Results - Earnings Call Transcript

Athenex, Inc. (ATNX) Q4 2021 Earnings Conference Call March 16, 2022, 4:30 PM ET Company Participants Johnson Lau – Chief Executive Officer Caileigh Dougherty – Investor Relations Dan Lang – President, Athenex Cell Therapy Kurt Gunter – Chief Medical Officer, Cell Therapy and Head, Regulatory Affairs Jeff Yordon – Chief Operating Officer Joe Annoni – Chief Financial Officer Conference Call Participants Jonathan Miller – Evercore ISI Kevin DeGeeter – Oppenheimer Kennen MacKay – RBC Capital Markets Matt Kaplan – Ladenburg Thalmann Yale Jen – Laidlaw & Company Presentation Operator Good day, ladies and gentlemen, and welcome to the Fourth Quarter 2021 Athenex Earnings Conference Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the conference over to Caileigh Dougherty, Director of Investor Relations.

For further details see:

Athenex, Inc. (ATNX) CEO Johnson Lau on Q4 2021 Results - Earnings Call Transcript